Bank Of The West Vertex Pharmaceuticals Inc Transaction History

Bank Of The West

$851 Million
Q4 2022

A detailed history of Bank Of The West transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of The West holds 1,229 shares of VRTX stock, worth $567,933. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,229

Previous 1,267 3.0%

Holding current value

$567,933

Previous $367,000 3.54%

% of portfolio

0.04%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$285.76 - $321.48 $10,858 - $12,216	-38 Reduced 3.0%	1,229 $354,000
Q3 2022 Oct 31, 2022	BUY	$273.83 - $305.53 $11,227 - $12,526	41 Added 3.34%	1,267 $367,000
Q2 2022 Aug 02, 2022	SELL	$234.96 - $292.55 $7,988 - $9,946	-34 Reduced 2.7%	1,226 $345,000
Q1 2022 Apr 22, 2022	SELL	$221.42 - $260.97 $8,413 - $9,916	-38 Reduced 2.93%	1,260 $329,000
Q4 2021 Jan 28, 2022	SELL	$177.01 - $223.45 $47,615 - $60,108	-269 Reduced 17.17%	1,298 $285,000
Q3 2021 Nov 09, 2021	SELL	$181.39 - $202.99 $11,064 - $12,382	-61 Reduced 3.75%	1,567 $284,000
Q2 2021 Aug 11, 2021	SELL	$187.49 - $221.1 $469,849 - $554,076	-2,506 Reduced 60.62%	1,628 $328,000
Q1 2021 May 10, 2021	SELL	$207.02 - $241.31 $67,074 - $78,184	-324 Reduced 7.27%	4,134 $888,000
Q4 2020 Feb 02, 2021	BUY	$207.01 - $276.09 $18,630 - $24,848	90 Added 2.06%	4,458 $1.05 Million
Q3 2020 Nov 05, 2020	SELL	$255.65 - $303.1 $566,520 - $671,669	-2,216 Reduced 33.66%	4,368 $1.19 Million
Q2 2020 Aug 10, 2020	SELL	$225.48 - $295.8 $71,928 - $94,360	-319 Reduced 4.62%	6,584 $1.91 Million
Q1 2020 May 08, 2020	SELL	$199.77 - $247.81 $202,167 - $250,783	-1,012 Reduced 12.79%	6,903 $1.64 Million
Q4 2019 Feb 10, 2020	SELL	$166.71 - $223.91 $10,502 - $14,106	-63 Reduced 0.79%	7,915 $1.73 Million
Q3 2019 Oct 28, 2019	BUY	$166.23 - $187.09 $56,518 - $63,610	340 Added 4.45%	7,978 $1.35 Million
Q2 2019 Jul 18, 2019	SELL	$164.61 - $190.37 $1,975 - $2,284	-12 Reduced 0.16%	7,638 $1.4 Million
Q1 2019 Apr 09, 2019	SELL	$163.73 - $194.7 $1.81 Million - $2.15 Million	-11,064 Reduced 59.12%	7,650 $1.41 Million
Q4 2018 Feb 07, 2019	BUY	$151.91 - $192.21 $1.4 Million - $1.77 Million	9,226 Added 97.24%	18,714 $3.36 Million
Q3 2018 Nov 02, 2018	BUY	$167.73 - $192.74 $99,967 - $114,873	596 Added 6.7%	9,488 $1.83 Million
Q2 2018 Jul 25, 2018	BUY	$145.72 - $169.96 $115,410 - $134,608	792 Added 9.78%	8,892 $1.51 Million
Q1 2018 May 08, 2018	BUY	$151.6 - $177.13 $197,686 - $230,977	1,304 Added 19.19%	8,100 $1.32 Million
Q4 2017 Feb 05, 2018	BUY	$137.28 - $155.55 $932,954 - $1.06 Million	6,796	6,796 $1.02 Million

Others Institutions Holding VRTX

# of Institutions

1,751

Shares Held

227M

Call Options Held

1.64M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of The West, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of The West with notifications on news.

Account